Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
206.05
-0.73 (-0.35%)
Oct 28, 2026, 9:45 AM EDT - Market open

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had revenue of $1.21B in the quarter ending June 30, 2026, with 15.55% growth. This brings the company's total for the last twelve months to $4.60B, up 12.59% year-over-year. In the year 2025, Jazz Pharmaceuticals had annual revenue of $4.27B with 4.88% growth. That makes Jazz Pharmaceuticals the 2,787th largest company in the world by revenue and 802nd in the United States.

Revenue (ttm)
$4.60B
Revenue Growth
+12.59%
P/S Ratio
2.92
Revenue / Employee
$1,592,140
Employees
2,890
Market Cap
13.38B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Total Neuroscience 2.88B 67.5%
  • Total Oncology 1.13B 26.5%
  • High-Sodium Oxybate AG Royalty 211.73M 5.0%
  • Other Royalty and Contract 34.01M 0.8%
  • Other Product 14.17M 0.3%

By Geography

Chart
  • United States 3.83B 89.8%
  • Europe 341.12M 8.0%
  • All Other Countries 94.87M 2.2%
Fiscal year ended Dec 31, 2025 See the full Jazz Pharmaceuticals breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.27B198.64M4.88%
Dec 31, 20244.07B234.75M6.12%
Dec 31, 20233.83B174.83M4.78%
Dec 31, 20223.66B565.14M18.26%
Dec 31, 20213.09B730.67M30.91%
Dec 31, 20202.36B201.81M9.34%
Dec 31, 20192.16B270.84M14.32%
Dec 31, 20181.89B272.23M16.82%
Dec 31, 20171.62B130.72M8.79%
Dec 31, 20161.49B163.17M12.32%
Dec 31, 20151.32B151.93M12.95%
Dec 31, 20141.17B300.45M34.44%
Dec 31, 2013872.42M286.44M48.88%
Dec 31, 2012585.98M313.70M115.21%
Dec 31, 2011272.28M98.50M56.68%
Dec 31, 2010173.78M45.33M35.29%
Dec 31, 2009128.45M60.94M90.26%
Dec 31, 200867.51M2.21M3.39%
Dec 31, 200765.30M20.45M45.58%
Dec 31, 200644.86M23.41M109.20%
Dec 31, 200521.44M--